临床药师参与1例单用阿司匹林患者PCI术后并发脑出血的案例分析  

Clinical Pharmacists' Participation in 1 Cases of Intracerebral Hemorrhage after PCI Alone in Aspirin Treated Patients

作　　者：罗美凤[1] 虞佳[1] 饶堃睿 曾会军 LUO Mei-feng;YU Jia;RAO Kun-rui;ZENG Hui-jun

机构地区：[1]南昌市第一医院药剂科,江西南昌330008

出　　处：《药品评价》2018年第24期58-61,共4页Drug Evaluation

基　　金：南昌市指导性科技计划项目;编号:洪科发计字[2016] 223号第4项

摘　　要：目的:探讨经皮冠状动脉介入术(PCI)后并发脑出血的抗栓治疗方案调整。方法:临床药师参与1例67岁单用阿司匹林女性患者PCI术后并发脑出血病例,通过查阅相关文献,结合患者情况,给予术后抗栓治疗方案调整的建议。结果:脑出血后暂停患者抗栓治疗,积极治疗并发症,脑出血第4天加用氯吡格雷片,复查CT,脑出血情况有所吸收,于第25日好转出院。结论:脑出血是PCI术后少见而严重的并发症,与多种因素相关,应综合评估患者出血与缺血风险,做到早期识别及时调整抗栓治疗方案。Objective:To investigate the adjustment of antithrombotic therapy for intracerebral hemorrhage after percutaneous coronary intervention(PCI).Methods:Clinical pharmacists participated in a67-year-old female patient with intracerebral hemorrhage after PCI.By consulting the relevant literature and considering the patient's situation,they gave suggestions on the adjustment of postoperative antithrombotic therapy.Results:After cerebral hemorrhage,the patients were suspended antithrombotic therapy and actively treated complications.Clopidogrel tablets were added on the4th day of cerebral hemorrhage.The CT scan showed that the situation of cerebral hemorrhage was absorbed and the patients were discharged on the25th day.Conclusion:Intracerebral hemorrhage(ICH)is a rare and serious complication after PCI.It is related to many factors.The risk of ICH and ischemia should be evaluated comprehensively so as to identify early and adjust the antithrombotic regimen in time.

关 键 词：经皮冠状动脉介入术 脑出血 临床药师 

分 类 号：R982[医药卫生—药品]